Term ends Jan 4, 2043 · High confidence
20-year base term ends Jan 11, 2041
Held by Askgene Pharma, Inc.
Filed Jun 21, 2022 as application 17/787,741 · Granted Apr 14, 2026
Base term plus 723 days of patent term adjustment (USPTO delay)
Today
2021
2043
Clock starts
Jan 11, 2021
Jan 11, 2021
Term ends
Jan 4, 2043
Jan 4, 2043
Granted
Apr 14, 2026
Apr 14, 2026
base term
patent term adjustment
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
723
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 723 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 11, 2021, when application PCT/US2021/013007, the earliest non-provisional in its chain, was filed (this one was filed Jun 21, 2022) | Jan 11, 2041 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +723 days, USPTO patent term adjustment record | Jan 4, 2043 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 4, 2043 | High confidence |
This family
| Application PCT/US2021/013007 | PCT application no patent term | no patent term |
| US 12,600,762 | this patent Jan 2043 | Jan 2043 |
| Application 19/548,829 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 21, 2022 Reel 60834, frame 315 | Lu, Yuefeng; Yu, Chunxiao; Lu, Jian-Feng (Jeff); Liu, Liqin | Askgene Pharma, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2043
Term ends Jan 4, 2043. Maintenance fees still fall due before then
Note
The 723 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.